Dr. David Raben is a board certified radiation oncologist. He completed his residency training in radiation oncology at John Hopkins Hospital (1991-1994). Presently, he is a full professor and scientist in the only NCI-designated Comprehensive Cancer Center in the Rocky Mountain region at the University of Colorado Denver (UCD). Dr. Raben in nationally recognized regarding his work in targeted therapies and radiation, primarily in GI, head and neck cancer and lung cancer. He served on the head and neck steering committee of the National Cancer Institute (NCI) sponsored radiation cooperative group (RTOG). In addition, he is a member of the genitourinary section of the Southwest Oncology Group (SWOG) and has extensive experience with both low dose rate (LDR) and high dose rate (HDR) brachytherapy.
The UCD Radiation Oncology Department was the only site approved by the RTOG in Colorado to participate in the national phase II HDR brachytherapy trial. In addition, Dr. Raben was the first radiation oncologist in the Rocky Mountain region to implement accelerated intensity modulated radiation to the prostate and pelvis, recently published in peer-reviewed journal. His focus has also been on blocking critical growth, invasion and angiogenic radiation therapy. He is an ad hoc reviewer for Cancer Research, Clinical Cancer Research, Head and Neck, Journal of Clinical Oncology, and the International Journal of Radiation Oncology Biology Physics. He serves as the Director of the radiological Science Core at the Cancer Center. Dr. Raben has contributed to more than 75 publications.
Publications